05/02/2026
Like many practitioners, Dr. Carla DiGirolamo ( ) once viewed menopausal hormone therapy more narrowly–generally through the lens of the four primary FDA indications for menopausal hormone therapy (vasomotor symptoms, GSM, bone health, and POI/early menopause).
As she’s learned more and worked more closely with active women in menopause, she’s come to “color outside the lines” more, because even if the data is mixed for many symptoms, hormone therapy is broadly safe, it’s not all or nothing, and many women get real relief.
This week we dive into how her thinking has evolved on hormone therapy, GLP-1 medications, testosterone, hormone testing, and what actually moves the needle for athletic women in the transition.
Tune in to Hit Play Not Pause wherever you get your podcasts and on YouTube!